| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Nov 11, 2025 | Sell(S) | 14K | $18.50 | $259K | 60K |
| Nov 11, 2025 | Sell(S) | 16K | $18.50 | $287K | 76K |
| Nov 11, 2025 | Sell(S) | 16K | $17.00 | $264K | 60K |
| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Nov 11, 2025 | Option exercise(M) | 14K | $10.15 | $142K | 108K |
Parsed from a single SEC EDGAR Form 4/A filing (accession 0001256230-25-000007) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for Theravance Biopharma, Inc.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.